| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/05/2012 | US20120004592 Compositions for solubilizing tissue |
| 01/05/2012 | US20120004311 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic b-cell lymphoma/leukemia-2 (bcl-2) |
| 01/05/2012 | US20120004310 Non-peptide bdnf neurotrophin mimetics |
| 01/05/2012 | US20120004296 Chroman derivatives, medicaments and use in therapy |
| 01/05/2012 | US20120004286 Long-acting veterinary polypeptides and methods of producing and administering same |
| 01/05/2012 | US20120004285 Erbb-3 (her3)-selective combination therapy |
| 01/05/2012 | US20120004279 Compositions and methods for modulating activity of capped small rnas |
| 01/05/2012 | US20120004278 Linc rnas in cancer diagnosis and treatment |
| 01/05/2012 | US20120004270 Selective Androgen Receptor Modulators |
| 01/05/2012 | US20120004236 Substituted triazolo-pyridazine derivatives |
| 01/05/2012 | US20120004198 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| 01/05/2012 | US20120004185 Polypeptide structural motifs associated with cell signaling activity |
| 01/05/2012 | US20120004184 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/05/2012 | US20120004183 Unnatural reactive amino acid genetic code additions |
| 01/05/2012 | US20120004182 Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells |
| 01/05/2012 | US20120004178 Biglycan mutants and related therapeutics and methods of use |
| 01/05/2012 | US20120004175 Inhibitors of nf-kb activity |
| 01/05/2012 | US20120004172 Screening method of anti-lung or esophageal cancer compounds |
| 01/05/2012 | US20120004125 Plant diacylglycerol acyltransferases |
| 01/05/2012 | US20120004124 Markers of regulatory t cell activation |
| 01/05/2012 | US20120003741 Hepatitis c virus expressing reporter tagged ns5a protein |
| 01/05/2012 | US20120003740 Electroporation apparatus and methods |
| 01/05/2012 | US20120003739 Populations of expanded and re-differentiated adult islet beta cells capable of producing insulin and methods of generating same |
| 01/05/2012 | US20120003738 Method For Amplification And Functional Enhancment Of Blood Derived Progenitor Cells Using A Closed Culture System |
| 01/05/2012 | US20120003737 Multipotent stem cells and uses thereof |
| 01/05/2012 | US20120003736 Methods for culturing undifferentiated cells using sustained release compositions |
| 01/05/2012 | US20120003735 Methods for Improving Viability and Productivity in Cell Culture |
| 01/05/2012 | US20120003720 Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same |
| 01/05/2012 | US20120003719 INFECTIOUS GENOTYPE 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a HEPATITIS C VIRUS LACKING THE HYPERVARIABLE REGION 1 (HVR1) |
| 01/05/2012 | US20120003703 Cellobiohydrolase variants |
| 01/05/2012 | US20120003700 Thermostable Alpha-Amylases |
| 01/05/2012 | US20120003697 High affinity antibodies to human il-6 receptor |
| 01/05/2012 | US20120003691 Method of isolation and purification of trypsin from pronase protease and use thereof |
| 01/05/2012 | US20120003683 Cells for indicating the preservation of biological samples |
| 01/05/2012 | US20120003678 Novel fructosyl peptide oxidase |
| 01/05/2012 | US20120003668 High resolution complex structure and allosteric effects of low molecular weight activators on the protein kinase pdk1 |
| 01/05/2012 | US20120003329 Use of A2B Adenosine Receptor Antagonists for Treating Pulmonary Hypertension |
| 01/05/2012 | US20120003299 Novel hsp90-targeted anti-cancer chimeric peptide |
| 01/05/2012 | US20120003276 Dermal micro-organs, methods and apparatuses for producing and using the same |
| 01/05/2012 | US20120003270 6-substituted isoflavonoid compounds and uses thereof |
| 01/05/2012 | US20120003266 Virus like particle compositions and methods of use |
| 01/05/2012 | US20120003254 Breast Cancer Vaccine |
| 01/05/2012 | US20120003253 C1orf59 peptides and vaccines including the same |
| 01/05/2012 | US20120003252 Isoforms of human somatostatin receptor type 5 produced by alternative processing and oligo-nucleotide pairs for detection thereof by pcr |
| 01/05/2012 | US20120003249 Immuno-molecules containing viral proteins, compositions thereof and methods of using |
| 01/05/2012 | US20120003242 Modulating pdx-1 with pcif1, methods and uses thereof |
| 01/05/2012 | US20120003241 Vaccine against botulism |
| 01/05/2012 | US20120003235 Anti-lymphotoxin antibodies |
| 01/05/2012 | US20120003233 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor |
| 01/05/2012 | US20120003231 Cell surface molecule mediating cell adhesion and signal transmission |
| 01/05/2012 | US20120003220 B7-DC Variants |
| 01/05/2012 | US20120003216 Fgf21 mutants and uses thereof |
| 01/05/2012 | US20120003211 Immunoglobulins with reduced aggregation |
| 01/05/2012 | US20120003210 NEONATAL Fc RECEPTOR (FcRn)- BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
| 01/05/2012 | US20120003196 Long lasting drug formulations |
| 01/05/2012 | US20120003195 In vitro micro-organs, and uses related thereto |
| 01/05/2012 | US20120003194 In vitro micro-organs, and uses related thereto |
| 01/05/2012 | US20120003190 Lateral ventricle cell compositions and use for treating neural degenerative diseases |
| 01/05/2012 | US20120003189 Materials and Methods to Enhance Hematopoietic Stem Cells Engraftment Procedures |
| 01/05/2012 | US20120003187 Biological medium for preserving a preparation of insulin-secreting cells |
| 01/05/2012 | US20120003186 Method for dedifferentiating adipose tissue stromal cells |
| 01/05/2012 | US20120003185 Bone-like prosthetic implants |
| 01/05/2012 | US20120003181 Novel Retinoid Inducible Factor and Uses Thereof |
| 01/05/2012 | US20120003178 Evaluating the therapeutic potential of a glucan |
| 01/05/2012 | US20120003175 Therapeutic uses of mastic gum fractions |
| 01/05/2012 | US20120003149 Novel monoclonal antibody, and use thereof |
| 01/05/2012 | DE102005046225B4 Verbessertes Zellkulturmedium Improved cell culture medium |
| 01/05/2012 | CA2803779A1 Il-13 producing tr1-like cells and use thereof |
| 01/05/2012 | CA2803641A1 Treatment of t-cell mediated immune disorders |
| 01/05/2012 | CA2803639A1 Method of treating graft versus host disease |
| 01/05/2012 | CA2803509A1 Immortalized avian cell lines |
| 01/05/2012 | CA2802896A1 Methods for culturing undifferentiated cells using sustained release compositions |
| 01/05/2012 | CA2801808A1 Novel microrna precursor and use thereof in regulation of target gene expression |
| 01/04/2012 | EP2402444A1 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 01/04/2012 | EP2402440A1 -glucan-deficient gene in barley, synthetic gene, and use of same |
| 01/04/2012 | EP2402439A1 Immunization method using cancer cell |
| 01/04/2012 | EP2402435A2 Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy |
| 01/04/2012 | EP2402434A1 Method for producing a scaffold suitable for cartilage cells |
| 01/04/2012 | EP2402373A2 Anti-EphB4 Antibodies and Methods Using Same |
| 01/04/2012 | EP2402359A1 Recombinant protective protein from streptococcus pneumoniae |
| 01/04/2012 | EP2402031A1 Immunologic adjuvant composition and use thereof |
| 01/04/2012 | EP2402019A1 Methods of treating disease by transplantation of allogeneic or xenogeneic organs or tissues |
| 01/04/2012 | EP2401376A2 Piggybac transposon variants and methods of use |
| 01/04/2012 | EP2401375A1 Improved design of small-interfering rna |
| 01/04/2012 | EP2401372A1 Novel nuclear reprogramming substance |
| 01/04/2012 | EP2401365A1 Reengineering mrna primary structure for enhanced protein production |
| 01/04/2012 | EP2401364A1 Differentiation of pluripotent cells |
| 01/04/2012 | EP2401363A1 Methods of reprogramming renal cells |
| 01/04/2012 | EP2401362A2 Isolated populations of renal stem cells and methods of isolating and using same |
| 01/04/2012 | EP2401361A2 Methods and compositions for stem cell cultures |
| 01/04/2012 | EP1971683B1 Adenylate cyclase, gene sequence coding for adenylate cyclase, vectors and cells, and the use thereof |
| 01/04/2012 | EP1805200B1 Neurotransmitter sensors and methods of using the same |
| 01/04/2012 | EP1644485B9 Secreted proteins as markers for cell differentiation |
| 01/04/2012 | EP1624847B1 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 01/04/2012 | EP1025194B2 Bleaching compositions comprising multiply-substituted protease variants |
| 01/04/2012 | CN102307995A Transformed soybean plant which stores vaccine, and use thereof |
| 01/04/2012 | CN102307992A Method for treating or preventing a pancreatic dysfunction |
| 01/04/2012 | CN102307991A Pluripotent stem cell culture on micro-carriers |
| 01/04/2012 | CN102307990A Methods of deriving differentiated cells from stem cells |
| 01/04/2012 | CN102307905A Production of carrier-peptide conjugates using chemically reactive unnatural amino acids |